The QualityStocks Daily Friday, December 21st, 2018

Today's Top 3 StockMarketWatch

StocksToBuyNow (ZNGY) +900.00%

QualityStocks (IGAP) +200.00%

OTCtipReporter (MICT) +178.30%

The QualityStocks Daily Stock List

Nano One Materials Corp. (NNOMF)

NetworkNewsWire, Wallmine, Central Charts, GuruFocus, Dividend Investor, MarketWatch, Investors Hangout, Private Capital Newswire, Charts and Trends, Penny Stock Tweets, Stockhouse, Insider Tracking, OTC Markets, Market Screener, Capital Cube, Wallet Investor, Canadian Insider, Barchart, 4-Traders, and Morningstar reported on Nano One Materials Corp. (NNOMF), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.

Nano One Materials Corp. is developing patented technology for the low-cost production of high-performance battery materials used in electric vehicles, energy storage and consumer electronics. Its mission is to establish its patented technology as a foremost platform for the global production of a new generation of nanostructured composite materials. Nano One Materials has its headquarters, laboratory, as well as pilot facility in Burnaby, British Columbia. The Company also has an office in Vancouver, British Columbia.

Nano One Materials currently has active contribution agreements with the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP), Sustainable Development Technology Canada, and the Automotive Supplier Innovation Program – all programs of the Government of Canada. All together, these funding sources are projected to extend the Company’s operating capital into Q1 2020.

The processing technology addresses fundamental supply chain constraints through enabling wide-ranging raw materials specifications for use in lithium ion batteries. This process can be configured for a range of varied nanostructured materials. Additionally, it has the flexibility to shift with developing and future battery market trends and a diverse range of other growth opportunities.

The novel three-stage process uses equipment common to industry. Nano One Materials has built a pilot plant to demonstrate high volume production and to optimize its technology across a range of materials.

The core technology assembles low-cost raw materials in solution (including lithium, cobalt, magnesium) at high rates of production, before industrial driers and kilns complete the reaction. The three-stage process can produce numerous kinds of ceramic powders. It is already being engineered, with industrial partners NORAM and BC Research, for high volume production and quick commercialization.

This week, Nano One Materials Chief Executive Officer, Mr. Dan Blondal, announced that the Company entered into a Joint Development Agreement with Saint-Gobain. The aim of this collaboration is to enhance high temperature processing of Nano One’s lithium ion battery materials. The two companies will work in collaboration, under the joint development agreement, to enhance the performance of its respective materials.

Saint-Gobain is a multi-billion euro French multinational corporation. It produces a broad array of construction and high-performance materials for applications in automotive, aerospace, health, and energy.

Nano One Materials Corp. (NNOMF), closed Friday's trading session at $0.949, up 0.82%, on 10,065 volume with 7 trades. The average volume for the last 3 months is 16,887 and the stock's 52-week low/high is $0.7174/$2.18.


Arch Biopartners, Inc. (ACHFF)

Stockwolf, Business Insider, Investors Hangout, OTC Markets, Barchart, Wallet Investor, Wall Street Alerts, Stockwatch, Marketwired, TradingView, InvestorPoint, Infront Analytics, 4-Traders, Stockhouse, and MarketWatch reported previously on Arch Biopartners, Inc. (ACHFF), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Arch Biopartners, Inc. is a portfolio-based biotechnology company headquartered in Toronto, Ontario. It centers on the development of innovative technologies that have the potential to make a significant medical or commercial impact. Arch Biopartners lists on the OTC Markets’ OTCQB.

The Company has established a diverse portfolio that includes Metablok (LSALT peptide). This is a potential treatment for inflammation, sepsis and cancer metastasis. Additionally, Arch’s portfolio includes AB569. This is a potential new treatment for antibiotic resistant bacterial infections in the lung, urinary tract or wounds.

Arch’s portfolio additionally includes ‘Borg’ peptide coatings. These coatings increase corrosion resistance and reduce bacterial biofilm on different medical grade metals and plastics. The Company’s two lead commercial technologies (MetaMx and ABP569) are on course to enter human clinical trials this year.

Metablok (renamed “LSALT peptide” in Arch Biopartners communications with the Food and Drug Administration [FDA]) is a novel peptide drug candidate in the Arch development pipeline. It is a potential treatment for inflammation, sepsis and cancer metastasis. MetaMx™ consists of novel, synthetic peptide, which target and attach to BTICs and invasive glioma cells, for the purpose of imaging, diagnosis, and developing targeted therapies to improve patient outcomes and survival rates among glioblastoma patients.

In August, Arch Biopartners announced it engaged Dalton Pharma Services to perform the good manufacturing practice (GMP) campaign for Metablok, (LSALT peptide), Arch's drug candidate for preventing acute kidney injury. Dalton Pharma Services will be responsible for the GMP preparation and filling of Metablok into glass vials through to the release of a clinical drug product.

In late September, Arch Biopartners announced that Dalton Pharma Services completed the good manufacturing practice (GMP) glass vial filling stage for Metablok. Over the next six to eight weeks Dalton will be completing the quality control process that will conclude with the release of a clinical drug product to be used in a Phase I safety trial for Metablok. Arch Biopartners is waiting for the completion of continuing toxicology and pharmacology studies at Nucro-Technics in November before confirming the commencement date of the Phase I human trial.

Arch Biopartners, Inc. (ACHFF), closed Friday's trading session at $0.98, up 18.07%, on 10,100 volume with 5 trades. The average volume for the last 3 months is 1,045 and the stock's 52-week low/high is $0.355/$1.37.


Asaleo Care Limited (ASLEF)

Penny Stock Tweets, Morningstar, Barchart, 4-Traders, Dividend Investor, Stockhouse, GuruFocus, MarketWatch, YCharts, The Street, Trade Ideas, Current Charts, Market Screener, TradingView, OTC Markets, Wallmine, Capital Cube and Wallet Investor reported earlier on Asaleo Care Limited (ASLEF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Established in 1932, Asaleo Care Limited is a leading personal care and hygiene Company. It manufactures, markets, distributes and sells essential everyday consumer products. These products cover the Feminine Care, Incontinence Care, Baby Care, Consumer Tissue and Professional Hygiene product categories. Asaleo Care is headquartered in Box Hill, Australia.

Asaleo Care is organized into three business units. These units are Consumer Tissue, Professional Hygiene, and Personal Care. Through its Consumer Tissue division, the Company manufactures and markets a number of leading consumer brands. These include Sorbent toilet and facial tissue, Handee paper towel, Deeko disposable tableware, Purex toilet tissue and Treasures nappies (New Zealand only).

Asaleo Care’s Professional Hygiene business delivers Tork hygiene solutions to the commercial, public, health care, food service and industrial segments. Through its Personal Care division, Asaleo Care manufactures and markets top personal hygiene products under the Libra feminine hygiene brand and the TENA incontinence brand. Asaleo Care supplies dispensers, paper towels, toilet tissue, soaps, napkins and industrial and kitchen wipers under the international Tork brand. Most of Asaleo’s brands hold number 1 or 2 market positions in Australia and New Zealand.

The Company also has its Pacific Islands initiative. Asaleo is well represented in the Pacific Islands via the distribution of a wide spectrum of Consumer Tissue, Tork Professional Hygiene and Personal Care products. In addition, Asaleo is well represented through the presence of a manufacturing site near Suva in Fiji. The Fijian plant produces toilet rolls, kitchen towels, serviettes, and facial tissues. The local brands Orchid and Viti are well known. These brands have market leadership in the Pacific Islands region.

Asaleo Care announced last month its partnership with REDcycle to decrease plastic packaging in landfills. Asaleo Care has partnered with REDcycle, which is a Melbourne based recycling organization that established a voluntary, industry-led initiative called the REDcycle Program. Furthermore, REDcycle is a signatory to the Australian Packaging Covenant.

The REDcycle program complements Asaleo Care’s partnership with the Tread Lightly program in New Zealand. This program educates school children about soft plastics recycling. It also establishes recovery systems in schools. Asaleo Care is also a member of the Love NZ Soft Plastics Recycling Scheme.  

Asaleo Care Limited (ASLEF), closed Friday's trading session at $0.685, up 4.58%, on 11,000 volume with 2 trades. The average volume for the last 3 months is 14,367 and the stock's 52-week low/high is $0.45/$1.34.


Wildflower Brands, Inc. (WLDFF)

Wallet Investor, Stockhouse, MarketWatch, Dividend Investor, TradingView, Morningstar, Financial Content, MicroCap Daily, Penny Stock Hub, Markets and Research, InvestorX, MicroSmallCap, Market Screener, InvestorsHub, and Pot Network reported previously on Wildflower Brands, Inc. (WLDFF), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

Wildflower Brands, Inc. is focusing on building reputable brands and quality products that incorporate the synergistic effects of plants and their extracts. The Company formerly went by the name Wildflower Marijuana, Inc. It changed its name to Wildflower Brands, Inc. in April 2018. OTCQB-listed, Wildflower Brands is based in Vancouver, British Columbia.

The Company’s mission is to connect people with the healing power of plants. Wildflower Brands develops its products through listening to the mature cannabis-smart consumers and experienced dispensary bud tenders’ feedback. It works to find the best technologies, use the highest quality cannabis, and pair it with the most synergistic ingredients to maximize the benefits of cannabis.

The Company offers a complete line-up of wellness focused cannabis infused products. All of its products are made in America by Wildflower in its GMP certified facilities and third-party lab tested for quality assurance and accurate labeling.

Regarding its retail locations, The Wildflower by Bridges General branded stores will feature Wildflower’s existing online catalog of products. They will also feature in-store only exclusive products designed specifically for the New York market.  Bridges General is a unique retail concept by Wildflower’s partner Retail Worx.

Earlier this month, Wildflower Brands, via its licensed cannabis retailer, announced that it launched delivery service in Los Angeles, California. The Company is hiring dozens of full-time delivery drivers to bring cannabis products directly to legal adults in the Los Angeles area. In addition, Wildflower will license technology from to help route deliveries efficiently, manage inventory and comply with California law.

Wildflower Brands plans to capitalize on hemp legalization. The Company is pleased with the passing of the 2018 Farm Bill. This Bill includes the Hemp Farming Act of 2018. The legislation is now awaiting Presidential signature. The Bill unequivocally removes hemp as a designated controlled substance, legalizing CBD in all 50 states.

Mr. William Maclean, Wildflower Brands’ Chief Executive Officer, said, “Wildflower has been a leader in promoting CBD into traditional retail outlets the past few years breaking down the misconceptions surrounding it.  With such a clear statement by Congress and the Senate on its legality we intend to be the leader in the expected exponential growth as public awareness grows on the health benefits of CBD.” 

Wildflower Brands, Inc. (WLDFF), closed Friday's trading session at $0.362, down 7.42%, on 14,879 volume with 17 trades. The average volume for the last 3 months is 31,865 and the stock's 52-week low/high is $0.009/$1.14.


Khiron Life Sciences Corp. (KHRNF)

Investors Hangout, TradingView, Wallmine, OTC Markets, Wallet Investor, Investing News, Capital Network, InvestorsHub, Pot Network, Penny Stock Hub, Stockwatch, Stockhouse, Midas Letter, Barchart, Morningstar, Proactive Investors, MarketWatch, Market Screener, and GuruFocus reported on Khiron Life Sciences Corp. (KHRNF), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Khiron Life Sciences Corp. is a Canadian integrated medical cannabis enterprise. It has its core operations in Colombia. Khiron is fully licensed in Colombia for the cultivation, production, domestic distribution, as well as international export of tetrahydrocannabinol (THC) and cannabidiol (CBD) medical cannabis. Khiron Life Sciences has its head office in Toronto, Ontario and an office in Bogota, Colombia. The Company’s shares trade on the OTC Markets Group’s OTCQB.

Khiron combines global scientific expertise, agricultural advantages, branded product market entrance experience and education to grow prescription and brand loyalty to address priority medical conditions. These conditions include chronic pain, epilepsy, depression and anxiety in the Latin American market. The Company is creating research partnerships with some of Colombia’s top medical associations – the Colombian Association of Neurology being one of them.

Khiron also has the advice of the best laboratories from Israel and Canada in genetics and, production and clinical data of medical cannabis. Concerning the cultivation process and product development, the Company has developed a temperature, humidity, and air circulation control system, which ensures that the plant grows in a controlled natural environment. Khiron’s cultivation is hydroponic.

Khiron Life Sciences announced in August of this year that it notified the Colombian Ministry of Justice that it expanded its cultivation area to 17.5 hectares of prime agricultural land near Ibague, Colombia . The cultivation site has an ideal climate profile, and an abundance of water, power, and skilled labor to scale cultivation and production. The cultivation area is in a highly secure region of Colombia.

Last month, Khiron Life Sciences announced that it signed the definitive agreement for the acquisition of the Latin American Institute of Neurology and the Nervous System (ILANS) earlier announced on August 7, 2018 . ILANS is one of the most respected, fastest growing, and largest neurological clinics in Colombia. It becomes a foundation of the Khiron Clinics business unit in Latin America.

Earlier this month, Khiron Life Sciences announced that it extended an agreement with Farmalisto, the region’s foremost digital drugstore, to market and distribute the Company's Kuida®  CBD cosmeceutical brand to a population of greater than 120 million consumers in Mexico. This is subject to approvals from the Federal Commission for the Protection of Health Risks (COFEPRIS).

Yesterday, Khiron Life Sciences announced that it received additional quotas from the Colombian Technical Quotas Group (TQG), to cultivate 5,040 psychoactive cannabis plants for the purposes of completing the Colombian Agricultural Institute (ICA) agronomic evaluation tests. This represents an important milestone towards the Company's stated timeline to bring medical cannabis options to market in Colombia.

Khiron Life Sciences Corp. (KHRNF), closed Friday's trading session at $0.989, down 8.09%, on 291,536 volume with 348 trades. The average volume for the last 3 months is 293,999 and the stock's 52-week low/high is $0.664/$1.587.


Integrity Applications, Inc. (IGAP)

SmallCapVoice and OTC Markets Group reported earlier on Integrity Applications, Inc. (IGAP), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Listed on the OTC Markets, Integrity Applications, Inc. is the maker of GlucoTrack®. This is a non-invasive device for measuring glucose levels in people with type 2 diabetes and pre-diabetes. GlucoTrack® is a monitoring device, which quickly measures and displays an individual's glucose level in approximately a minute without finger pricking or any pain. GlucoTrack® has received CE Mark and KFDA approvals for type 2 diabetes and pre-diabetes. It is presently in the early stages of commercialization in Europe, South Korea, and other geographies. Established in 2001, Integrity Applications is a Delaware corporation with headquarters in the U.S. and a research and development (R&D) site in Ashdod, Israel.

GlucoTrack® features a small sensor. This sensor clips to the earlobe and measures the user's glucose level employing unique and patented sensor technology. The measured signals undergo analysis utilizing a proprietary algorithm and subsequently a calculated glucose level is displayed on a small handheld device the size of a small mobile phone.

The glucose results are stored in the device and used to project an estimated HbA1c level using a proprietary algorithm. Also, the device can display glucose values graphically, enabling the user to monitor glucose levels over time.

The expectation is that GlucoTrack® will start clinical trials for United States Food and Drug Administration (FDA) approval in late 2017. The product is now experimental in the U.S. It is limited to investigational use only.

Recently, Integrity Applications announced new data demonstrating the clinical performance of GlucoTrack, further supporting its suitability for people with type 2 diabetes across different medication regimes. The data were recently presented at the American Diabetes Association's (ADA) 77th Scientific Sessions in San Diego, California.

GlucoTrack (following the collection of 7,700 total measurements) demonstrated comparable clinical and numerical accuracies among all participants. This was regardless of medication regime. Across medication groups, the clinical accuracy of GlucoTrack® ranged from 97.5 percent to 99.2 percent in the clinically acceptable A and B zones of the Consensus Error Grid. All medication groups showed clinical accuracy above 72.5 percent in the A zone. In addition, no statistical difference was observed in mean and median absolute relative difference within each medication group (p>0.05).

In early August, Integrity Applications announced that it successfully closed a private placement offering, raising roughly $12 million over the past 16 months. Accredited investors bought units comprising one share of Series C preferred stock, convertible into shares of Integrity Applications’ common stock at $4.50 per share, and two warrants to purchase shares of the Company's common stock at $4.50 and $7.75 per share, respectively.

The transaction was led by Mr. Andrew Garrett, a New York, New York based full-service investment bank and Integrity Applications’ investment advisor, which acted as sole placement agent.

Mr. John Graham, Chairman and CEO of Integrity Applications, stated “This ongoing source of capital has provided us with resources to continue our progress towards a truly non-invasive solution to glucose measurement and, in addition supports the initial commercialization of GlucoTrack in Europe, as well as advances our clinical and regulatory efforts in the U.S. and China."

Integrity Applications, Inc. (IGAP), closed Friday's trading session at $0.30, up 200.00%, on 6,661 volume with 5 trades. The average volume for the last 3 months is 2,536 and the stock's 52-week low/high is $0.10/$2.50.


Gold Reserve, Inc. (GDRZF)

Savvy Trader Resource, 4-Traders, The Street, Stockhouse, OTC Markets, MarketWatch, Otc. Watch, The Otc Reporter, Barchart, Business Wire, Equities, InvestorsHub, Investors Hangout, Super Stock Screener, GuruFocus, and Morningstar reported previously on Gold Reserve, Inc. (GDRZF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Gold Reserve, Inc. acquires, explores, and develops mining projects. It has a history in mining dating back to 1956 and established for the purpose of acquiring, exploring, and developing mining properties and placing them into production. An exploration stage enterprise, Gold Reserve is based in Spokane, Washington and the Company’s shares trade on the OTC Markets Group’s OTCQX.

Gold Reserve`s aim is to successfully develop proven and probable reserves through making selective property and/or corporate acquisitions. In 1992, Gold Reserve acquired and began developing what is now known as the Brisas gold and copper project, situated in the historic Km 88 mining district of the State of Bolivar in southeastern Venezuela. The Brisas deposit contains ore reserves of 10.2 million ounces of gold and 1.4 billion pounds of copper.

On March 1, 2016, Gold Reserve completed the acquisition of certain wholly-owned mining claims called the LMS Gold Project (LMS Property), together with certain personal property for $350,000, pursuant to a Purchase and Sale Agreement with Raven Gold Alaska, Inc., a wholly-owned subsidiary of Corvus Gold, Inc. The LMS Property remains at an early stage of exploration. It is not material to Gold Reserve.

Gold Reserve announced earlier this year that the mixed company Empresa Mixta Ecosocialista Siembra Minera S.A. (SM), owned 45 percent by Gold Reserve and 55 percent by the Bolivarian Republic of Venezuela, received the Permit to Effect for the Siembra Minera Gold Copper Project (SM Project) from the Venezuelan Ministry of the Environment. The Permit to Effect will allow site clearing, construction of a temporary camp and warehouse facilities, drilling of dewatering and development drill holes, construction of access roads on the property, and opening of the quarry for construction aggregates.

Last week, Gold Reserve announced that for the nine months ended September 30, 2018 it had Net Earnings After Tax of US$67.8 million or US$0.68 per share versus US$81.8 million or US$0.89 per share in the same period of 2017. For the three months ended September 30, 2018 Gold Reserve had Net Earnings After Tax of US$3.7 million or US$0.04 per share versus US$34.3 million or US$0.36 per share in the same period of last year.

Gold Reserve completed a positive NI-43-101 compliant Preliminary Economic Assessment (PEA) on the Siembra Minera project this year and completed preliminary design and cost estimates and related tailings dam facilities for the Small Plant. It also initiated activities associated with the preparation of a Venezuela Environment Impact Statement (VEIS) and International Environmental and Social Impact Assessment (IESIA), collected a surface saprolite material sample for transport to the U.S. for metallurgical testing and acquired the permit to effect the environment for the Siembra Minera Project (Permit to Effect) from the Venezuelan Ministry of the Environment.

Gold Reserve, Inc. (GDRZF), closed Friday's trading session at $2.15, down 0.46%, on 31,526 volume with 10 trades. The average volume for the last 3 months is 8,660 and the stock's 52-week low/high is $1.84/$3.51.


Integra Resources Corp. (IRRZF)

High Rising Stocks, The Hot Penny Stocks, Barchart, The Prospector News, Stockwolf, TradingView, Penny Stock Hub, Investing News Alerts, and Dividend Investors reported previously on Integra Resources Corp. (IRRZF), and we also report on the Company, here at the QualityStocks Daily Newsletter.

Integra Resources Corp. engages in the acquisition, exploration and development of mineral properties in the Americas. The Company’s primary emphasis is the advancement of its DeLamar Project. The Company formerly went by the name Mag Copper Limited. It changed its name to Integra Resources Corp. in August 2017. A development-stage enterprise listed on the OTCQX, Integra Resources is headquartered in Vancouver, British Columbia.

Its DeLamar Project consists of the neighboring DeLamar and Florida Mountain Gold and Silver Deposits in the heart of the historic Owyhee County mining district in southwestern Idaho. The DeLamar Project consists of roughly 5,300 acres of patented and unpatented claims, and a further 4,100 acres of leased lands with around 1,575 historic drill holes and 145,940 meters of drilling outlined in historic databases.

In 2018, Integra Resources commenced a $10 million drill program at DeLamar. The 2018 exploration program includes aggressive drilling, metallurgical testing, geophysical surveys, and field sampling, mapping and prospecting. In addition, it includes a technological approach to targeting.

Integra Resources has acquired a 100 percent interest in the Empire Claim Group for USD $1.6 million. The Empire Claim Group covers greater than 95 percent of the past producing Florida Mountain gold-silver Project. Integra Resources’ interest is free of all royalties and other kinds of financial encumbrances. With the agreement, Integra Resources acquired 36 patented mining claims totaling approximately 440 acres.

Last month, Integra Resources announced the remaining drill results from its 100 percent owned Florida Mountain Gold-Silver Deposit. A total of 2,920 meters (m) was completed in 9 drill holes at Florida Mountain during the 2018 drill campaign, designed to test the low-grade disseminated mineralization and select high-grade veins on the Deposit. With these results signifying the end of the 2018 Florida Mountain drill campaign, one exploration drill remains active on the Company’s neighboring DeLamar Deposit. It will remain active throughout the winter. Drilling is scheduled to continue in H1 2019 at Florida Mountain.

In February of this year, Integra Resources reported a maiden Florida Mountain Deposit inferred mineral resource utilizing a 0.3 g/t AuEq cut-off, outlining 36,605,000 tonnes grading 0.57 g/t Au and 14.12 g/t Ag, for a total of 675,000 ozs of Au and 16.6 M ozs Ag, or 871,000 oz AuEq at a grade of 0.74 g/t AuEq.

Integra Resources Corp. (IRRZF), closed Friday's trading session at $0.561, up 0.56%, on 36,600 volume with 12 trades. The average volume for the last 3 months is 32,403 and the stock's 52-week low/high is $0.05/$1.83.


ProBility Media Corporation (PBYA)

NetworkNewsWire, MarketWatch, Morningstar, Marketwired, Barchart, The Street, OTC Markets, Dividend Investor, InvestorsHub, StockTrot, Topstocksnews, Marketbeat, Penny Stock Hub, Wallmine, YCharts, Simply Wall St, and Stocks to Buy Now reported previously on ProBility Media Corporation (PBYA), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.

ProBility Media Corporation is a technology business offering immersive technologies, digital learning and compliance solutions for the education and training markets. The Company serves customers from the individual to the small business to the enterprise level corporation. In January 2018, ProBility Media acquired DISCO Learning Media, an online course developer and digital publisher.

ProBility Media has its head office in Houston, Texas, with offices in Florida, New York, and Vermont. ProBility Media is an education technology (EdTech) company. The Company’s shares trade on the OTC Markets.

The Company offers premier training courses and materials and works to prepare the workforce for excellence. It is executing the strategy of defragmenting the marketplace of thousands of disparate companies through acquiring smaller companies in the areas of its expertise and organically building revenue through synergies.

ProBility Media is looking for acquisition targets that service engineering firms, electrical contractors, fabricators, plumbing contractors, pipe fitters, riggers, and qc firms and additional vocational industries. ProBility, by way of its electrical training division, is becoming the largest wholesaler of electrical codes and exam prep material in the United States. In addition, through its construction training division, it offers programs in 22 states. This division serves one of the largest certification markets in the United States.

The Company’s DISCO Learning Media entered into an agreement to help The University of Texas System launch Careers in Chemistry, a new game-based experience inside Minecraft: Education Edition aimed at highlighting chemistry-related career opportunities to high school students. University of Texas at Austin associate professor of instruction in chemistry and science entertainer Dr. Kate Biberdorf will help guide the project and supervise the career curriculum.

Austin-headquartered education agency, DISCO Learning Media, provided instructional and media content support. DISCO Learning Media, a creative education agency, eCourse developer and digital publisher, is a division of Probility Media.

ProBility Media Corporation (PBYA), closed Friday's trading session at $0.0003, even for the day, on 25,707,645 volume with 25 trades. The average volume for the last 3 months is 9,282,611 and the stock's 52-week low/high is $0.0002/$0.3065.


Trevali Mining Corporation (TREVF)

Investopedia, Investing News, Resource World, Street Insider, Junior Mining Network, Northern Miner, Tip Ranks, Stockwatch, Streetwise Reports, MarketWatch, OTC Markets, InvestorsHub, Stockhouse, YCharts, Marketwired, Capital Cube,, GuruFocus, StockInvest, and Emerging Growth reported earlier on Trevali Mining Corporation (TREVF), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Trevali Mining Corporation is a zinc-focused, base metals company listed on the OTC Markets’ OTCQX. Its strategy includes reaching mid-tier Mining Company status through a combination of organic growth and unique deals and strategic alliances. The Company is a pure-play producer with industry-leading leverage to zinc with 80 -85 percent of revenue coming from zinc production. Trevali Mining has its corporate office in Vancouver, British Columbia.

The Company is centering exploration activities in highly prospective, under-explored terrain in nations and regions that offer security of tenure and support mineral deposit development. Production has risen each year for five straight years. Resources at all mines remain open for expansion with exploration drill programs continuing. Glencore is a cornerstone strategic shareholder - 25.6 percent.

Trevali Mining has four mines. These are the wholly-owned Santander mine in Peru, the wholly-owned Caribou mine in the Bathurst Mining Camp of northern New Brunswick, the Company’s 80 percent owned Rosh Pinah mine in Namibia, and its 90 percent owned Perkoa mine in Burkina Faso.

Regarding the Bathurst Mining Camp, Trevali Mining acquired five strategic mineral claim blocks from partner Glencore subject to a 2 percent NSR (Net Smelter Return) for any future production for a total of 3,520 ha of area, expanding Trevali's total land holdings to 11,380 ha in the Camp. The Company also owns the Halfmile and Stratmat base metal deposits in New Brunswick. Currently, these are undergoing a Preliminary Economic Assessment (PEA) reviewing their potential development.

Trevali Mining and Puma Exploration, Inc. completed their Phase 1 Drilling Program on the Murray Brook Deposit. The Program consisted of 4,481 meters of drilling within 13 new holes and the deepening of hole MB17-01. The Murray Brook Deposit - the core of the Strategic Alliance between the companies - is 10 kilometers west of Trevali’s Caribou Mine and 10 kilometers east of Trevali’s Restigouche Deposit in the Bathurst Mining Camp of New Brunswick.

Recently, Trevali Mining reported a downgrade of the 2018 production guidance for the Caribou mine because of challenging rock mass conditions. The expectation is that increased zinc production from Perkoa operations will partially offset metal losses. Trevali reiterated it remains on course to realize its 2018 consolidated zinc production guidance.

Trevali Mining Corporation (TREVF), closed Friday's trading session at $0.2589, down 5.61%, on 512,205 volume with 22 trades. The average volume for the last 3 months is 109,530 and the stock's 52-week low/high is $0.2716/$1.37.


Delcath Systems, Inc. (DCTH)

OTC Markets, SuperStockScreener, StocksGallery, 4-Traders, Barchart,, Morningstar, Stock News Journal, Stocktwits, TradingView, MarketWatch, and Insider Financial reported on Delcath Systems, Inc. (DCTH), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Delcath Systems, Inc. is an interventional oncology Company focused on the treatment of primary and metastatic liver cancers. Its investigational product is Melphalan Hydrochloride for Injection for use with the Delcath Hepatic Delivery System (Melphalan/HDS). The design of this product is to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. OTCQB-listed, Delcath Systems is headquartered in New York, New York.

The Company has supported clinical research of liver directed high dose chemotherapy in patients with metastatic ocular and cutaneous melanoma, metastatic colorectal cancer, metastatic neuroendocrine tumors, and hepatocellular carcinoma.  Liver directed high dose chemotherapy uses percutaneous hepatic perfusion (PHP) to deliver concentrated doses of a chemotherapeutic agent directly to the liver.

Since 2012, Delcath’s system has been commercially available in Europe under the trade name Delcath Hepatic CHEMOSAT® Delivery System for Melphalan (CHEMOSAT). In Europe, it has been used at major medical centers to treat a wide variety of cancers of the liver.

Delcath is working on advancing its clinical programs of its innovative Melphalan/HDS. Melphalan/HDS has not been approved by the U.S. Food & Drug Administration  (FDA) for sale in the U.S.  Furthermore, the Company is working to increase commercialization efforts for CHEMOSAT in Europe. Delcath continues its emphasis on the clinical trials that consist of the Clinical Development Program (CDP).

Delcath Systems has started a global Phase 3 FOCUS clinical trial for Patients with Hepatic Dominant Ocular Melanoma (OM). It plans to start a worldwide registration trial for intrahepatic cholangiocarcinoma (ICC).

This week, Delcath Systems announced that the independent Data Safety Monitoring Board (DSMB) of the Registration trial for Patients with Hepatic Dominant Ocular Melanoma (The FOCUS Trial) completed another pre-specified review of safety data for treated patients in the trial. The review was conducted on data collected from the previous randomized protocol and the amended single-arm protocol for the FOCUS Trial. The DSMB again recommended continuation of the study without modification.

The FOCUS Trial is enrolling a minimum of 80 patients with ocular melanoma metastatic to the liver. Patients earlier enrolled under the prior randomized protocol continue to be treated and evaluated as part of the amended trial. Periodic DSMB reviews will continue to take place.

Delcath Systems, Inc. (DCTH), closed Friday's trading session at $0.285, up 5.95%, on 31,526 volume with 10 trades. The average volume for the last 3 months is 26,498 and the stock's 52-week low/high is $0.23/$49.00.


Noble Roman’s, Inc. (NROM)

FeedBlitz, Equity Clock, Penny Stock Tweets, Stockopedia Penny Stock Hub, Investor Village, Tip Ranks, Simply Wall St, TaglichBrothers, Insider Financial, Marketbeat, The Bowser Report, Wallet Investor, StockOodles, Wall Street Resources, YCharts, MicroCapClub, and SmallCapVoice reported on Noble Roman’s, Inc. (NROM), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Noble Roman's, Inc. sells and services franchises and licenses for non-traditional foodservice operations and stand-alone take-n-bake locations. Its business model consists of three growth venues. These are Grocery Take-n-Bake Licensing; Non-Traditional Franchising; and Stand-Alone Franchising. OTCQB-listed, Noble Roman’s has its head office in Indianapolis, Indiana.

The Company franchises and licenses under the Noble Roman’s Pizza, Noble Roman’s Take-N-Bake, Tuscano’s Italian Style Subs, and Noble Roman's Craft Pizza & Pub (CPP) trade names. It has awarded franchise and/or license agreements in all 50 U.S. States plus Washington, D.C. Noble Roman’s also has awarded franchise and/or license agreements in Canada, Puerto Rico, the Bahamas, Italy, and the Dominican Republic.

The first Noble Roman's Craft Pizza & Pub (CPP) opened on January 31, 2017 in Westfield, Indiana. Noble Roman's announced in May 2018 that it opened a fourth location of its new-generation, stand-alone pizzeria concept, Noble Roman's Craft Pizza & Pub (CPP) in Carmel, Indiana.

The Company’s intention is to expedite the development of Craft Pizza & Pub (CPP) locations by way of franchising. General franchising is planned for Indiana and surrounding areas with a focus on franchisees that can become multi-unit operators. Furthermore, Noble Roman’s will also pursue development of other markets deemed suitable for the concept with experienced multi-unit operators.

Regarding the Company’s three growth venues,  Grocery Take-n-Bake Licensing involves licensing to sell Noble Roman’s Pizza. This is a component program using Noble Roman’s ingredients, in which delis assemble pizzas from standard Noble Roman’s ingredients.

Concerning Stand-Alone Venues, these are traditional pizzeria locations and Take-n-Bake locations. There is a merging over time between the kinds of Stand-Alone Venues: Live Yeast Dough; Hand-Rolled Breadsticks; and Baking Services.

Pertaining to Non-Traditional Venues, these are usually located in a host facility whose principal business is other than foodservice. These facilities can add pizza-focused foodservice as a Revenue Center; as a Facility Draw; and as an Employee Benefit.

This week, Noble Roman's announced that starting last Thursday, December 13, 2018, it started the initial roll-out of its new curbside carry-out service at its Fisher's Craft Pizza & Pub location. The design of the Company's new curbside delivery service for carry-out customers is to create added value and convenience for its carry-out customers. Customers calling in carry-out orders are invited to park in designated parking spaces in front of the restaurant. Here, employee Pizza Valets get orders out fast and conveniently without the guest having to step out of their vehicle.

Noble Roman’s, Inc. (NROM), closed Friday's trading session at $0.40, even for the day, on 25,173 volume with 9 trades. The average volume for the last 3 months is 29,087 and the stock's 52-week low/high is $0.379/$0.87.


American Power Group Corp. (APGI), Stock News Now, and SmallCapVoice reported on American Power Group Corp. (APGI), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

American Power Group Corp. designs and produces proven alternative fuel solutions for stationary power generators, backup power systems, and commercial transportation. The Company’s alternative energy subsidiary, American Power Group, Inc. (APG), provides a cost-effective patented Turbocharged Natural Gas® Dual Fuel Conversion Technology for vehicular, stationary, as well as off-road mobile diesel engines. American Power Group is headquartered in Lynnfield, Massachusetts and lists on the OTC Markets Group’s OTCQB.

The Company’s patented Turbocharged Natural Gas® Dual Fuel Conversion Technology is a unique non-invasive software driven solution. It converts existing vehicular and stationary diesel engines to run simultaneously on diesel and different kinds of natural gas. This includes compressed natural gas, liquefied natural gas, conditioned well-head/ditch gas or bio-methane gas with the flexibility to return to 100 percent diesel fuel operation at any time.  It is a ground-breaking non-invasive energy enhancement system.

American Power Group (with its proprietary Flare to Fuel™ process technology) can convert captured gases into natural gas liquids (NGLs) that can sell as heating fluids, emulsifiers, or be further processed by refiners. Via the Company’s Trident Associated Gas Capture and Recovery Technology, it can provide oil and gas producers a flare capture service solution for associated gases produced at their remote and stranded well sites.  

Regarding American Power Group’s dual fuel, methane gas is metered into a diesel engine's air intake, before the turbocharger, by the air filter. As the enriched air/gas mixture increases the engine's power, the diesel's own governor senses the power increase and backs off on diesel flow. The system maintains a balance of gas-to-diesel ratios.

The maintaining of the energized fuel balance is with a proprietary read-only electronic controller system. This ensures the engines operate at original equipment manufacturers' (OEMs) specified temperatures and pressures. Installation on a broad collection of engine models and end-market applications demands no engine modifications.

Yesterday, American Power Group announced that it will extend the filing of its June 30, 2017 Quarterly Form 10Q through SEC Form 12b-25.  The Company announced on June 6, 2017, a corporate wide realignment of its strategic direction, reallocation of resources, and reduction in workforce in response to considerable operating losses because of the effect that ongoing low oil prices were having on its dual fuel and flare capture businesses. The realignment resulted in a decrease in annual operating costs of greater than $2 million on a going forward basis.

American Power Group Corp. (APGI), closed Friday's trading session at $0.109, up 9.00%, on 17,000 volume with 3 trades. The average volume for the last 3 months is 36,626 and the stock's 52-week low/high is $0.0025/$0.1375.


Omnitek Engineering Corp. (OMTK)

OTCPicks,, FeedBlitz, and Penny Stock Rumble reported earlier on Omnitek Engineering Corp. (OMTK), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Omnitek Engineering Corp. develops and sells proprietary diesel-to-natural gas conversion systems and complementary products. This includes new natural gas engines that utilize the Company’s technology. These provide its international customers with unique alternative energy and emissions control solutions that are sustainable and affordable. Omnitek Engineering has its head office in Vista, California.

The Company’s conversion technology provides fleets with a 100 percent dedicated natural gas engine at a fraction of the cost of a new natural gas engine. The strategic alliance provides an assembly-line remanufacturing process providing the benefits of capacity, consistency, as well as quality. Omnitek Engineering’s commitment is to be at the frontier of technology. In addition, its commitment is to develop pioneering solutions that redefine the future of low emissions, energy independence, and transportation.

Omnitek’s products include New Natural Gas Engines, Engine Specific Diesel-to-Natural Gas (DNG) Engine Conversion Kits, and products for Diesel-to-Natural Gas Engine Conversions, Engine Management System (EMS) and Components, EFI for V-Twin Motorcycles and Small Engines, and Hydrogen Internal Combustion Engines. The DNG system has established Omnitek Engineering as a leader in the industry.

The Company has established a strategic alliance with LKQ Corp. to produce "drop-in" natural gas engines at Omnitek Engineering’s facility in Monterrey, Mexico, first for the extensively-used Mercedes OM904 and OM906 engines. LKQ is a top provider of alternative and specialty parts to repair and accessorize automobiles and other vehicles.

Omnitek Engineering announced in July of 2016 that it received global certification for its patented fuel rail technology. This is founded on tests conducted by an independent agency and standards sanctioned by the United Nations Economic Commission for Europe, specifically UN ECE R110.

Omnitek Engineering will participate in a $1.5 million grant study with its partner Olson-Ecologic Testing Laboratories (Fullerton, California). The study is to demonstrate its clean natural gas engine technology for off-road heavy duty construction vehicle applications in the greater Los Angeles, California area.

Omnitek will develop an 18-liter Caterpillar natural gas engine capable of operating on CNG, LNG, or low-carbon intensive renewable biogas (R-CNG) through using its patented diesel-to-natural gas engine conversion technology.  Olson-Ecologic Engine Testing Laboratories will serve as project manager. Olson-Ecologic will be responsible for rigorous testing at its facility before demonstrations under real-life conditions.

This month, Omnitek Engineering reported results for its Q2 and six months ended June 30, 2017. The results reflect a significantly reduced Net Loss for both periods, an improved cash position, as well as the start of an earlier announced grant program to develop an 18-liter off-road natural gas engine.

Net Revenues for Q2 were $246,314 versus $252,316 the year prior.  For the same period, Omnitek reported a Net Loss of $191,589, or $0.01 per share, versus a Net Loss of $292,939, or $0.01 per share, the year prior.

Net Revenues for the six-month period were $537,968 versus $591,899 the year prior. For the same period, it reported a Net Loss of $400,630, or $0.02 per share, versus a Net Loss of $489,683, or $0.02 per share, the year prior.

Omnitek Engineering Corp. (OMTK), closed Friday's trading session at $0.1095, up 28.75%, on 913 volume with 1 trade. The average volume for the last 3 months is 13,568 and the stock's 52-week low/high is $0.057/$0.469.


The QualityStocks Company Corner

BriaCell Therapeutics Corp. (OTC: BCTXF) (TSX.V: BCT)

The QualityStocks Daily Newsletter would like to spotlight BriaCell Therapeutics Corp. (BCTXF).

Cancer patients facing limited therapeutic options are the focus for a team of scientists and clinicians at BriaCell Therapeutics Corp. (OTCQB: BCTXF) (TSX.V: BCT), a clinical-stage biotechnology company developing safe and effective immunotherapy treatments for advanced breast cancer patients. BriaCell’s immunotherapy, Bria-IMT, is the company’s lead product candidate. The company recently presented promising results for two of its clinical studies (monotherapy and combination study of Bria-IMT with pembrolizumab [KEYTRUDA®; manufactured by Merck & Co., Inc.]) for patients with advanced breast cancer during the 2018 San Antonio Breast Cancer Symposium in Texas (

BriaCell Therapeutics Corp. (OTC: BCTXF) (TSX.V: BCT), based in Berkeley, CA, and headquartered in Vancouver, British Columbia, is a clinical-stage biotechnology company focused on the development of targeted immunotherapy for advanced breast cancer.

BriaCell hopes to develop and market the first off-the-shelf personalized immunotherapy for the treatment of advanced breast cancer.

The results of two previous proof-of-concept clinical trials produced encouraging results in patients with advanced breast cancer. Most notably, one patient with breast cancer that had spread to other sites (metastatic cancer) responded to Bria-IMT™ with a substantial tumor shrinkage in multiple sites including the breast, the lung, soft tissues and even the brain. Similar observations have been confirmed more recently in additional patients, and BriaCell is developing BriaDX™ as a way to identify those patients most likely to respond.

BriaCell has recently completed recruitment of a Phase I/II study (NCT03066947) of Bria-IMT™, the Company’s lead product candidate, in advanced breast cancer patients showing an outstanding safety profile and excellent efficacy. BriaCell is currently enrolling advanced breast cancer patients in a combination therapy trial (NCT03328026) of Bria-IMT™ with Keytruda® (Keytruda® is a registered trademark of Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.) or Yervoy® (Yervoy® is a registered trademark of Bristol-Myers Squibb Company). For further information on the Phase IIa clinical trials, please visit trial NCT03066947 and trial NCT03328026.

BriaCell’s pipeline also includes Bria-OTS™, the first off-the-shelf personalized immunotherapy for advanced breast cancer; and, a companion diagnostic product BriaDX™. By using BriaDX™ to identify and treat the patients who would most likely benefit from their immunotherapies, BriaCell expects to personalize the treatment for the patients, and bring hope to thousands of cancer patients who currently have few-to-no treatment options.

Breast Cancer Statistics

The National Cancer Institute estimates that more than 265,000 new cases of female breast cancer will be diagnosed in the U.S. during 2018, and that more than 40,000 women in the U.S. will die from the disease. Approximately 12 percent of women will be diagnosed with breast cancer at some point during their lifetime, based on 2013-2015 data.

Using its novel technology platform and strong R&D capabilities, BriaCell believes it has the opportunity to address this market, as well as have the opportunity to develop immunotherapy candidates for other cancer indications.

The global cancer immunotherapy market is expected to reach nearly USD$203 billion by 2025.

BriaCell Therapeutics Corp. (BCTXF), closed the day's trading session at $0.06, up 13.41%, on 25,000 volume with 1 trade. The average volume for the last 3 months is 17,358 and the stock's 52-week low/high is $0.053/$0.135.

Recent News


Generation Alpha, Inc. (GNAL)

The QualityStocks Daily Newsletter would like to spotlight Generation Alpha, Inc. (GNAL).

CannabisNewsWire released a report featuring Generation Alpha, Inc. (GNAL) today which examines how the election of a new government in Mexico paved the way for quick steps to be made towards the legalization of recreational cannabis. Now the foreign minister of the country has told a Mexican Senate committee that lessons are going to be drawn from countries and jurisdictions where legalization has already occurred.

Generation Alpha, Inc. (GNAL) was established in 2010 as a vertically integrated technology innovator, developer, manufacturer and distributor focused on bringing products and solutions to both commercial and individual growers in the United States. Originally named Solis Tek Inc., the company changed its name to Generation Alpha in September 2018 and announced an increased focus on providing innovative and must-have cannabis products and services to a growing industry.

“Generation Alpha for us means ‘new beginning’” said Generation Alpha CEO Alan Lien, when the name change was announced. “It is the new wave of how people and brands connect. We are excited with the transformation of our business strategy, our progress at our Arizona facility and the additional growth opportunities our team has identified elsewhere in the cannabis industry. While we are pleased with our innovation and progress in our Solis Tek lighting and Zelda Horticulture divisions, we believe?Generation Alpha?represents our philosophy of bringing the best cannabis products and services to the market. We are confident that this shift in our business strategy will create long-term shareholder value through diversified segments in the legalized cannabis industry.”

The name change reflects the company’s strategy to leverage business opportunities in different legalized cannabis spaces, including cultivation, processing and retail facilities. As part of that focus, Generation Alpha acts as the holding entity for a collection of companies that bring products and solutions to legal retail and commercial cannabis growers while utilizing its expertise to offer safe, quality and consistent products through its cultivation, processing, and retail facilities as well as branded products in both the medical and recreational markets. Along with its strong focus on the burgeoning cannabis market, Generational Alpha remains committed to developing and providing innovative products and services in both Solis Tek Digital Lighting, its lighting division, and Zelda Horticulture, its agricultural products division.

As part of a key piece of its cannabis focus, Generation Alpha acquired a cannabis cultivation and processing facility in Phoenix, Arizona, which is scheduled to begin operation in 2019. Currently in the design and development stage, the 70,000-square-foot facility will be one of the most technologically advanced cultivation and processing facilities in Arizona, which is a hot bed of cannabis cultivation in North America. Generation Alpha management is confident about the growth and profitability this facility provides as an essential component of its forward-thinking cannabis strategy.

Additional components of this strategy include the company’s GrowPro Solutions, Inc., a nationwide cannabis cultivator and processor and a variety of Generation Alpha brands, which include the innovation, design and selling of cannabis?products such as flower, oils and accessories in the legal medical and recreational markets.

The company’s Zelda Horticulture division offers commercial-grade rolling tables, greenhouses, PH stabilizer and nutrient products, and other agricultural products for cultivators around the world. Zelda’s custom-design cultivation options means its clients can count on increased agricultural productivity and efficiency.

Generation Alpha’s Solis Tek Digital Lighting division offers an extensive line of lighting equipment and accessories, including digital ballasts, reflectors,?complete lighting systems, single- and double-ended digital lamps, controllers and other accessories.?Each product is designed to help retail and commercial growers maximize quality and achieve higher yields and maximize quality.?

Generation Alpha, Inc. (GNAL), closed the day's trading session at $0.44, up 7.32%, on 87,974 volume with 35 trades. The average volume for the last 3 months is 68,342 and the stock's 52-week low/high is $0.37/$2.64.

Recent News


Marijuana Company of America Inc. (MCOA)

The QualityStocks Daily Newsletter would like to spotlight Marijuana Company of America Inc. (MCOA).

Marijuana Company of America Inc. (MCOA), an innovative hemp and cannabis corporation, is extremely optimistic about the Company’s current and future endeavors with the recent passing of the 2018 Farm Bill on December 20 after an 87 to 13 majority vote in the Senate and a 369 to 47 majority vote in the House and final approval by President Trump.

Marijuana Company of America Inc. (OTC: MCOA) (the “Company”) are pioneers in the cannabis industry going back to 2009 when Don Steinberg, MCOA’s CEO, founded the first marijuana company ever to trade on a U.S. stock market, Medical Marijuana Inc. Since then, Don and his partner, Charlie Larsen, have formed Global Hemp Group and Marijuana Company of America. They have experienced the shift of legislation first hand, not only for the legalization of marijuana but also the emerging hemp-based CBD products.

The CBD market is growing exponentially and consequently the founders of MCOA have constructed their business model around the development of industrial hemp-based CBD products. The industrial hemp plant can be used to produce products that are carbon neutral or even carbon negative. It is one of the longest, strongest natural fibers on earth, used as a building material that is free of mold, pesticide-resistant, and fire proof. Hemp has also been described as a “super food,” which provides additional business opportunities. No part of the plant is left unused and the Company’s overall strategy is to take advantage of every profit center from farm to the multiple valuable finished products.

The cannabis and hemp industries are experiencing unprecedented growth that is expected to continue for many years as these industries are now accepted globally and continue to mature and expand. North American consumers spent $6.7 billion on legal cannabis products in 2016, up 34% from 2015’s $5 billion. This trend is widely expected to explode at a 27% compounded annual growth rate to reach $22.6 billion by 2021, according to ArcView Market Research.

The company offers investors the opportunity to be on the forefront of cannabis and hemp innovation through cultivation, processing in the legal cannabis and industrial hemp sectors. The Company’s business model includes producing a diverse portfolio of synergistic business segments that provide value to its shareholders. Its vertically integrated business model and distribution platforms are positioned to capture market share by developing recognizable and valuable brands.

Under the MCOA umbrella, wholly owned subsidiary hempSMART™, Inc. is committed to bringing high quality CBD-based products to the market through its affiliate marketing program. Through hempSMART, MCOA’s strategic approach to the distribution of products is through a networking architecture geared to maintain customer loyalty and capture market share. The patent-pending product “hempSMART Brain,” is designed to revolutionize the safe and effective support of healthy brain function. The brand new product, HempSMART DROPS, is a full-spectrum CBD tincture formulated with hemp and fractionated coconut oils. The hempSMART marketing team has decades of experience, and is well positioned to take the hempSMART brand to a global audience.

Marijuana Company of America Inc. (MCOA), closed the day's trading session at $0.02145, up 6.19%, on 17,125,876 volume with 668 trades. The average volume for the last 3 months is 13,159,588 and the stock's 52-week low/high is $0.0115/$0.0728.

Recent News


Pacific Software, Inc. (PFSF)

The QualityStocks Daily Newsletter would like to spotlight Pacific Software, Inc. (PFSF).

In early November, Pacific Software (OTC: PFSF) served as a co-sponsor of Latin America Night at the 124th session of the Canton Fair Product Development Council (“PDC”) Design Show in Guangzhou, China. To view the full article, visit:

Pacific Software, Inc. (PFSF) is focused on the design, development, and distribution of Hyperledger blockchain technology solutions for application to the specific needs of agriculture and the opioid epidemic.

The basic requirements of the systems to be developed include high-throughput transaction processing, traceability or tracking, visibility or monitoring, and transparency throughout the supply and value chains for the stakeholders. The development of this architecture will serve as an online commercial portal to service Pacific Software’s B2B accounts in the sectors below.

For application of its Agri-blockchain based system, Pacific Software will target farm-to-consumer exports to increase transparency, combat theft and counterfeit products, and reduce the health risks associated with shipping “tainted” agricultural products to other countries.

Controlled Substances
With the misuse of opioids on the rise worldwide, Pacific Software aims to apply its blockchain-based system to track opioids from pharmaceutical production to consumers and attempt to identify “Bad Actors” in the supply chain and fight against the global epidemic.

Business Model
The portal will be structured in a B2B format where clients will pay the company transaction fees, royalties, cash, cash equivalents and other forms of compensation to utilize its Hyperledger blockchain applications for their business models.

As the company executes these strategies, each Hyperledger blockchain-based system designed may be organized separately in wholly owned subsidiaries. To enhance its portfolio of holdings, Pacific Software may consider investments in companies where selected markets have imminent profitable results, providing appreciable value for investors and shareholders.

Pacific Software, Inc. (PFSF), closed the day's trading session at $5.50, even for the day. The average volume for the last 3 months is 63 and the stock's 52-week low/high is $3.50/$5.50.

Recent News


Cyberfort Software, Inc. (CYBF)

The QualityStocks Daily Newsletter would like to spotlight Cyberfort Software, Inc. (OTC: CYBF).

Cyberfort Software, Inc. (OTC: CYBF) is competing in the high-growth cyber security industry, which is seen by analysts as having a bright future. Research firm Markets and Markets predicts that the cyber security market will reach $248 billion by 2023 from 2018’s $153 billion, representing a CAGR of 10.2 percent from 2018-2013 (

Cyberfort Software, Inc. (CYBF) is a cybersecurity technology company specializing in the acquisition and development of security software, content filtering, and ad blocking technology. Headquartered in San Francisco, California, Cyberfort Software is actively dealing with various cyber threats through the development of innovative protection technologies designed for mobile, personal and business tech devices across multiple platforms.

Committed to the idea that everyone – from individuals to global corporations – should be able to enjoy a digital future free of malicious attacks robbing them of privacy and security, Cyberfort is working to strengthen its portfolio of cybersecurity IPs and stay one step ahead of cyberthreats. The growing plethora of tech devices enveloping everyday life opens the door to increasing cyberattacks through a stunning array of sophisticated cyberthreats. Protecting organizations and individuals with proactive security postures and protective measures is a key component of Cyberfort’s strategy to develop cybersecurity solutions that are smart, simple and efficient.

The company’s 2016 purchase of Vivio, a provider of pioneering AI content filtering and software protection, underscores Cyberfort’s commitment to cybersecurity. Vivio, an iOS 10 ad blocking app, currently serves over 10,000 unique users across iPhone, iPad and Mac. Vivio makes web browsing better, faster and more satisfying by blocking ads and reducing data usage, which also helps save battery life. Continuous ad blocking rule updates are delivered via an Intellectual Property Cloud-based autonomous engine with ad blocking tracker and malware detection filters.

Cyberfort recently signed a letter of intent to acquire Just Content Software which includes the Just Content app, software and underlying source code. Just Content is an efficacious and multi-functional ad blocking app that safeguards families and businesses with proprietary “Home Safe Filter” and “Business Filter” products. The Just Content app is available on iTunes and protects against unsafe links, adult content, phishing sites and inflammatory hate speech found on the internet, among other potential backdoor attacks and cyberthreats. A due diligence review is underway and a final determination regarding this acquisition is anticipated within weeks.

“Cyberfort aims to become a leader in developing cutting edge ad-blocking protective software that keeps the internet safe for families and business, which in our highly technological and immediate information-access society is a significant concern. Acquiring Just Content furthers our commitment to provide the best and most effective ad-blocking software in the marketplace,” says Cyberfort CEO Daniel Cattlin.

Favorable government regulations promoting tightened web security is a major factor driving adoption of web content filtering solution along with the public’s growing desire to better manage network bandwidth consumption and protect their online security and privacy. Cyberfort’s objective is to protect the data and integrity of personal and business computing assets and defend those assets against any threat or attack. The company’s software also offers symbiotic ad-blocking capabilities to complement its cyber defense effectiveness.

As Cyberfort continues to innovate, the Vivio team intends to leverage the current user base as a sandbox to test and optimize future incremental developments targeting an enterprise suite of tools that can be integrated into sector specific areas of growth. Key areas of focus include mobile device management, bring your own device (“BYOD”), mobile app management and secure mobile browser.

The Cyberfort leadership team is headlined by Cattlin, who offers a new age perspective to the business with expertise in project and asset management and a background in corporate finance. Cattlin brings both the operational and financial understanding to take companies from start-up and early development to expansion and capital growth within a public environment.

Chief Technology Officer Tomas Mistrik helped his team deliver a variety of technological products including the Vivio ad-blocking app for iOS 10 and the Silicon Valley-based Synergykit platform for mobile developers.

Technology Development Manager Krishna Kumar brings more than 10 years of experience in the Information Technology industry where he provided powerful security and ad-blocking measures for companies such as CSC and PayPal India.

Senior Advisor Harish Doddala brings nine years of product management and software engineering experience, delivering results for Cisco, VMware, Oracle, IBM and Siemens.

Cyberfort Software, Inc. (OTC: CYBF), closed the day's trading session at $0.38, up 2.70%, on 1,200 volume with 3 trades. The average volume for the last 3 months is 18,109 and the stock's 52-week low/high is $0.051/$69.00.

Recent News


Youngevity International, Inc. (NASDAQ: YGYI)

The QualityStocks Daily Newsletter would like to spotlight Youngevity International, Inc. (YGYI).

NetworkNewsAudio announces the Audio Press Release (APR) titled “Coffee Brands See Stellar Growth in Amazon Sales,” featuring Youngevity International, Inc. (NASDAQ: YGYI). To hear the NetworkNewsAudio version, visit: To read the full editorial, visit:

Youngevity International, Inc. (NASDAQ: YGYI) is a leading omni-direct lifestyle company offering a hybrid of the direct selling business model that includes e-commerce and the power of social selling. Among the Top 100 Global Direct Selling Companies, Youngevity offers products from the six top selling retail categories: health/nutrition, home/family, food/beverage (including coffee), spa/beauty, apparel/jewelry, and a range of innovative services. Created through the 2011 merger of Youngevity Essential Life Sciences with Javalution® Coffee Company, today’s Youngevity International Inc. is a virtual worldwide Main Street of products and services under one corporate entity that supports a healthy and empowered lifestyle.

Youngevity International is dedicated to improving lifestyles through the universal desires of vibrant health and flourishing economics. Catering to health-conscious consumers, Youngevity believes that combining the best of the direct selling industry with the fundamentals and capabilities of a traditional business model will maximize shareholder value. The company’s Nutritional, Lifestyle and Telecommunications products and services are distributed through a global network of Preferred Customers and Distributors.

Youngevity’s wholly owned CLR Roasters LLC business line offers quality branded and private label coffee to retail stores, office coffee services, hospitality, food services, distributors, convenience, petrol stores and vending businesses. Today, CLR Roasters is the largest coffee provider for cruise lines in North America and the second largest roaster in the state of Florida. Producing a consistent premium product with superior taste, CLR Roasters has earned numerous certifications that demonstrate the company’s commitment to the craft of providing the highest quality coffee products using the best practice standards available.

Youngevity, operating in the direct-selling channel, is rapidly expanding its product and distributor base through acquisitions and mergers under an innovative concept called “the Network Cloud” that provides other direct selling companies with a home base. The company’s YoungevityGO2 mobile distributor app, a new technology-driven web platform supporting expansion of global e-commerce and social selling platforms, is available on Google Play and the App Store. In addition to the Network Cloud concept, Youngevity International owns CLR Coffee Roasters which operates a traditional coffee roasting business offering a JavaFit® gourmet product line that vertically integrates with Youngevity and its growing network of direct marketers.

Youngevity International offers more than 1,000 high quality, technologically advanced products under the following categories:

  • Health and Nutrition
  • Home and Family
  • Food and Beverage
  • Spa and Beauty
  • Fashion
  • Essential Oils
  • Photo and scrapbooking
  • Services for Home and Business

Youngevity International Inc. has compiled a best-in-class management team with a strong track record of success in private and public companies. Steve Wallach, CEO, has nearly two decades of sales and network marketing experience and has successfully guided Youngevity International Inc. to become an international, publicly-traded direct marketing company positioned for worldwide growth. Dave Briskie, president and CFO, has shepherded the company’s development into a fully vertical coffee roasting and distribution company that owns the direct marketing brand JavaFit® and the retail brand, Café La Rica.

Youngevity has also attracted a stunning group of Brand Evangelists who endorse its products. Among these are actress, author and well-known health and wellness activist Marilu Henner; former NBA basket player, Mike “Stinger” Glenn; former NFL wide receiver Drew Pearson; “Greatest Natural Bodybuilder in the World” Gene Nelson; and WNBA champion, Olympic gold medalist Delisha Jones.

Youngevity International, Inc. (NASDAQ: YGYI), closed the day's trading session at $6.34, off by 4.66%, on 143,293 volume with 716 trades. The average volume for the last 3 months is 561,761 and the stock's 52-week low/high is $3.167/$16.25.

Recent News


Net Element (NASDAQ: NETE)

The QualityStocks Daily Newsletter would like to spotlight Net Element (NETE).

The year of 2018 has proven to be an eventful one for Net Element, Inc. (NASDAQ: NETE), a payment-as-a-service transactional and value-added services provider. Net Element was the recipient of numerous important recognitions, and market trends are suggesting that 2019 will be marked by additional growth and accomplishments. Mid-December, international corporate magazine news site ACQ5 announced its annual global awards, honoring those whose work has been definitive for setting the standard in their respective niches (

Net Element (NETE), is a global financial technology and value-added solutions group that supports electronic payments acceptance in an omni-channel environment spanning across point-of-sale, e-commerce, and mobile devices. Net Element operates a payments-as-a-service transactional model and value-added services platform for small to medium enterprises in the U.S. and selected emerging markets. Internationally, Net Element’s strategy is to leverage its omni-channel platform to deliver flexible offerings to emerging markets with diverse banking, regulatory and demographic conditions. Net Element was ranked as one of the fastest growing companies in North America on Deloitte’s 2017 Technology Fast 500 ™ and South Florida Business Journal’s 2016 fastest growing technology companies.

Net Element believes the future of global commerce is being revolutionized as consumers quickly migrate toward omni-channel shopping utilizing mobile devices, desktop, and online services. Net Element’s all-in-one payment solutions support and unify a whole range of applications through a single, robust platform, allowing global onboarding and support for multiple payment methods.

With an eye on emerging markets, Net Element is pursuing growth opportunities and footholds in a number of industries. The company’s most recent application of its technology is to the cannabis industry, which is paced to hit $591 million and could increase 40 times in the next four years. This rampant growth also creates heightened need for smooth transactions between merchants and consumers. Payment processing and compliance for the cannabis industry has become increasingly complex, and Net Element’s Unified Payments subsidiary is addressing the challenges by offering a compliant, seamlessly integrated payment solution that makes it simple to transact.

Net Element has also launched a blockchain-focused business unit that will develop and deploy blockchain technology-based solutions. Net Element expects the new division to create a decentralized crypto-based ecosystem that will act as a framework for an unlimited number of value-added services, connecting merchants and consumers in a seamless, economically efficient transaction. This new business unit intends to also identify and invest in unique projects that decentralize and disrupt the payment processing industry by combining blockchain technology and real-world applications with talented development teams, strong fundamentals and addressable markets large in size.

“We believe that we’re at the dawn of a new evolution where additional digital payment methods are being introduced,” Net Element CEO Oleg Firer, says. “Introduction of our division focused on blockchain as part of the NASDAQ-listed entity will add transparency and compliance assurance to our investors as well as provide access to deploy value-added services to over 20 million electronic commerce clients that are currently part of Net Element’s growing network.”

Net Element clients are treated to customized solutions that provide the flexibility needed to keep up with customers. Among the services offered are mobile payment apps that accept payments anywhere, anytime; cloud-based solutions built to increase productivity and enhance revenue for clients and partners; marketing solutions that turn lookers into buyers; and business analytics that make it easy for clients to monitor business metrics, engage with customers and compare the competition. Its multi-channel platform combines e-commerce, offline, point-of-sale, comprehensive back office tools, mobile point-of-sale, credit scoring and customer interaction in one powerful platform-as-a-service technology.

Net Element owns and operates a global mobile payments and transactional processing provider, TOT Group, Inc., with the following subsidiaries:

  • Unified Payments – An award-winning, customized mobile billing and payments solution, recognized by Inc. Magazine as the No. 1 Fastest Growing Company in America in 2012.
  • Digital Provider – A leading provider of SMS messaging and mobile billing solutions.
  • Aptito – A next-generation, all-in-one, cloud-based restaurant management and point-of-sale payments platform using wireless technology.
  • Payonline – A fully integrated, processor agnostic electronic commerce platform.

Net Element is ranked No. 418 on Deloitte’s 2017 Technology Fast 500™ list of North America’s 500 fastest growing technology, media, telecommunications, life sciences and energy tech companies. Net Element grew 190 percent. The company’s chief executive officer, Oleg Firer, credits the company’s progression to organic growth in its North America Transactions Segment, specifically the success of its Unified Payments brand, which focuses on value-added payment acceptance solutions for small to medium enterprises in the United States.

“The Deloitte 2017 North America Technology Fast 500 winners underscore the impact of technological innovation and world class customer service in driving growth, in a fiercely competitive environment,” said Sandra Shirai, vice chairman, Deloitte Consulting LLP and U.S. technology, media and telecommunications leader. “These companies are on the cutting edge, and are transforming the way we do business.”

Net Element’s suite of application performing interfaces (APIs) and connectors power commerce for businesses of all sizes through multi-channel platforms, all-in-one digital solutions, and end-to-end encryption of cardholder data utilizing tamper resistant hardware that ensures integrity and simplifies security.

Net Element’s corporate team is led by director and CEO Oleg Firer, who is responsible for the overall vision, strategy and execution of the company’s mission of powering global commerce. He is joined by CFO Jeffrey Ginsburg, CPA, and Steven Wolberg, who is the company’s chief legal officer and secretary. Each corporate officer brings a unique blend of leadership, vision, experience and creative energy to the company.

From mobile payments and value-added transactional innovations such as Digital Provider and Aptito to e-commerce and retail payment transaction processing brands like Payonline and United Payments, Net Element is transforming the online and mobile experience.

Net Element (NETE), closed the day's trading session at $5.94, off by 9.73%, on 145,192 volume with 756 trades. The average volume for the last 3 months is 307,926 and the stock's 52-week low/high is $3.75/$33.51.

Recent News


VIVO Cannabis Inc. (TSX.V: VIVO) (OTC: VVCIF)

The QualityStocks Daily Newsletter would like to spotlight VIVO Cannabis Inc. (VVCIF).

VIVO Cannabis Inc. (TSX-V: VIVO, OTCQX: VVCIF) ("VIVO" or the "Company") today announced that it has retained NATIONAL Capital Markets to provide investor relations and financial communications services. "Our premium brands, quality operations and disciplined approach to growth will now be supported and enhanced by a best-in-class investor communications program," stated Barry Fishman, Chief Executive Officer of VIVO. "We look forward to having NATIONAL support our team, set best practices, and most importantly, communicate with our stakeholders in an informative and reliable manner."

VIVO Cannabis Inc. (TSX.V: VIVO) (OTC: VVCIF) is a globally licensed, cost efficient producer of premium quality, organic, standardized medicinal cannabis. One of the earliest licensed medical marijuana producers under Canada’s federally-controlled Access to Cannabis for Medical Purposes Regulations (ACMPR), VIVO has five years of operating experience in the burgeoning medical marijuana space through its flagship operation, ABcann Medicinals, Inc. The company recently received its Health Canada license to produce medical cannabis oils and is working toward production of saleable, extracted, finished products that will lead to a final inspection allowing sales of its oils.

“Receipt of the license to produce cannabis oils is a major milestone in our pursuit to provide our medical cannabis patients with additional product formats that can be precisely dosed. The expansion and innovation of our product lines are a top priority for the Company as we continue to serve the needs of our customers, and we anticipate strong demand for our cannabis oil products,” VIVO CEO Barry Fishman said.

VIVO owns and operates a fully functioning 14,500 square foot facility in Napanee, Ontario, which is being doubled in size to produce 1,400 kg of cannabis per year. The company’s expansion plans include adding a seasonal greenhouse and a hybrid, multipurpose facility, capable of producing 31,000 kg of cannabis per year between the two facilities, to be constructed on 65 acres it already owns near the Napanee facility. This additional location is properly zoned with existing infrastructure in place for an eventual 1.2 million square feet of production space.

VIVO has built a reputation over the years for its best-in-class standardized approach to growing cannabis that includes the absence of pesticides and a computer monitored growing technique that provides a consistent, pharmaceutical-grade with high yields. The company’s custom, scalable growing chambers with proprietary lighting can be replicated anywhere in the world, leading to lower production costs. This technique has helped it record a customer retention rate of 94.7 percent alongside 30 percent month-over-month customer growth. When combined with VIVO’s current yield rate, which it has measured at roughly 100 percent greater than the industry average, the company has constructed a strong foundation upon which to build a sizable presence in the global cannabis industry.

This global growth potential is illustrated by VIVO’s partnership with Israel’s Syqe Medical, producer of the world’s first selective-dose pharmaceutical grade medicinal plant inhaler. After visiting VIVO’s production facility, Perry Davidson, founder of Syqe Medical, noted that the company’s production technologies put it “in a class with the best in the world” in its ability to produce standardized pharmaceutical grade cannabis.

VIVO’s recent acquisition of Harvest Medicine Inc. represents further progress toward the company’s goal of becoming a vertically integrated medical cannabis company. Harvest Medicine is one of the fastest growing medical cannabis clinics in Canada – adding over 1,200 new patients monthly from a single location – with an aggressive expansion plan and a patient-focused approach that perfectly aligns with VIVO’s philosophy of quality and innovation.

VIVO’s seasoned management team, board of directors and advisory board features well over a century of combined industry experience. Fishman, who has over 20 years of experience as a business leader, previously served as CEO of both Teva Canada and Taro Canada, as vice president of marketing at Eli Lilly Canada, and as past chair of the Canadian Generic Manufacturers Association. He most recently served as CEO of international specialty pharmaceutical company Merus Labs.

Notably, VIVO also has access to the ‘Father of Cannabis Research’, Raphael Mechoulam, PhD, through its board of advisors. An organic chemist and professor of medicinal chemistry at the Hebrew University of Jerusalem, Mechoulam was the first scientist to isolate both cannabidiol (CBD) and tetrahydrocannabinol (THC). He has received more than 25 prestigious academic awards, including the Rothschild Prize in Chemical Sciences and Physical Sciences in 2012.

With more than 65 acres of growth capacity, a healthy cash balance to fund upcoming construction efforts, steady sales growth, industry-leading yield rates and an established operations team in place, VIVO is well positioned to compete in the rapidly expanding Canadian cannabis industry and beyond.

VIVO Cannabis Inc. (VVCIF), closed the day's trading session at $0.4686, off by 7.21%, on 805,005 volume with 339 trades. The average volume for the last 3 months is 375,879 and the stock's 52-week low/high is $0.500/$3.29.

Recent News


Phivida Holdings Inc. (CSE: VIDA) (OTC: PHVAF)

The QualityStocks Daily Newsletter would like to spotlight Phivida Holdings Inc. (PHVAF).

Hemp-cultivated cannabinoid innovator Phivida Holdings (CSE: VIDA) (OTCQX: PHVAF) recently commented on the successful passing of the 2018 Farm Bill. To view the full press releases, visit: and

Headquartered in Vancouver, Canada, with operations offices in southern California, Phivida Holdings Inc. (CSE: VIDA) (OTC: PHVAF) is a premium food and beverage company that develops CBD-infused functional foods, beverages and supplements poised for global distribution. All products in the Phivida label are infused with organic, hemp-derived cannabinoids into a variety of premium foods, beverages and clinical products for everyday health. Phivida is guided by a team of Fortune 500-caliber executives focused on a new strategic portfolio of products and brands, comprehensive consumer research, new product and brand development, improved visual identity and packaging design, and a strong distribution strategy.

The company’s motto – “Celebrating Health and Wellness, in Harmony™” – underscores Phivida’s mission to lead the alternative health care sector as the benchmark standard in premium CBD-infused functional beverages and tinctures. To execute this goal, Phivida is taking advantage of positive legislative developments in the United States and has defined an elevated national route-to-market strategy across the U.S. where small regional distributors will be now be replaced with large national distributors.


Phivida’s management team includes president and CEO Jim Bailey, former president of Red Bull Canada and global chief marketing officer for Merrell Outdoors; Chief Marketing Officer Michael Cornwell, former chief marketing officer for Samsung New Zealand and the former director of marketing for Red Bull Canada; and Doug Campbell, former director of sales for Red Bull North America, who as Phivida’s chief commercial officer is tasked with driving new sales revenue growth.

Publicly traded on the Canadian Securities Exchange (CSE.VIDA) and recently graduated to the OTCQX Best Market in the USA (OTCQX.PHVAF), the company’s strong balance sheet carries CAD$15.7 million with no debt or loans with less than 60 million shares outstanding and the company is now well-capitalized to fun major mainstream distribution with a solid structure poised for long-term growth.

The Science

Using encapsulation technology, Phivida uses full spectrum CBD-hemp oil (rich in naturally occurring phytocannabinoids) converted into a water-soluble delivery format, which enhances delivery and absorption of the cannabinoids into the human body – up to an estimated tenfold.

Encapsulated CBD is infused into functional beverages, food and supplements containing a proprietary blend of phytonutraceuticals studied to target a range of health and wellness conditions. Phivida tests every product for microbials, heavy metals, pesticides, residual solvents, terpenes, and potency to guarantee less than 0.3 percent THC (tetrahydrocannabinol, the chemical compound in cannabis responsible for a euphoric high) is present.


Federally legal under the 2014 Farm Bill, CBD from Hemp Oil is a rapid growth market across the USA. When derived from marijuana, CBD remains a schedule one controlled substances, giving hemp derived CBD oil infused products a competitive advantage on regulations. On June 28, 2018, the U.S. Senate passed the Agriculture Improvement Act of 2018 (i.e. the “Farm Bill), lifting the USA Industrial Hemp laws to an agricultural commodity status and effectively removed hemp from the controlled substance list.

Earlier this year, another milestone court ruling also provided significant regulatory support for the US CBD-Hemp sector. In February 2018, the Supreme Court preceded over the HIA (Hemp Industry Association) vs. DEA (Drug Enforcement Agency) in a class-action suit concerning the issue of CBD extracted from hemp, and the legality of industrial hemp. In the final ruling the Supreme Court unequivocally determined that – when produced domestically under the Farm Bill – hemp (and its derivatives) are not a controlled substance.

The Supreme Court ruling also found the Farm Bill (as it relates to hemp) “pre-empts” the Controlled Substances Act. Congress has since exempted Farm Bill hemp from the Controlled Substances Act (CSA) giving the Farm Bill primary jurisdiction over the governance of the CBD-Hemp Oil industry in the USA.

The DEA further conceded it does not “seek to control cannabinoids,” and that only marijuana derived cannabinoids are governed under the Controlled Substances Act. In May of 2018, the DEA issued a formal directive to all federal agencies (e.g. US Customs and Border Patrol) stating that cannabinoids are not controlled substances unless derived from marijuana, and that the “mere presence of cannabinoids” in any product or derivative does not render it a controlled substance. The Supreme Court ruling also resulted in the mediation of a settlement in what is now the third successful HIA vs. DEA suit in over a decade.

In Canada, the Senate approval of Bill C-45 legalized the production, distribution and use of recreation cannabis – with edibles to be added in 2019. The bill will officially become law as of October 17, 2018, creating a legal framework for the production, distribution, sale and possession of cannabis across Canada including cannabinoid-infused beverages.

3 Wholly Owned Subsidiaries

  • Phivida Organics Inc. offers professional-grade, wholesale, whole plant hemp oil extracts made from 100-percent certified organic hemp stalk. Phivida’s hemp oil extracts are CO2-extracted under quality assurance/clinical standards and are third-party lab tested to assure only pharmaceutical grade, cGMP certified, full-spectrum products are produced and available for sale. Phivida Organics produces hemp oil extracts that deliver nano-encapsulated cannabinoids in water soluble formulations designed to be absorbed up to 10 times faster than other oils, providing up to 400 percent bioavailability. Phivida Hemp Oil Vida+ extract products are available now online at
  • Phivida Nutrition blends the best of nature into CBD-infused lifestyle branded beverages including a variety of CBD infused iced teas and CBD infused flavored waters.
  • Phivida Enhanced – Under the VIDA brand, CBD-infused tinctures, capsules and other supplement products are distributed to alternative health care clinics across the USA.


Phivida has signed a binding letter of intent to joint venture WeedMD Inc. (TSX-V: WMD) (OTC:WDDMF) (FSE:4WE), a Health Canada federally licensed producer and distributor of medical cannabis, to form a joint venture focused on cannabis-infused beverages. The new joint-venture company, Cannabis Beverages Inc. (“CanBev”), plans to develop a production facility at WeedMD’s state-of-the-art greenhouse facility in Strathroy, Ontario, Canada. CanBev is on track to build and operate the first cannabis-infused beverage production facilities in Canada. The joint venture will focus on manufacturing, marketing and distribution of cannabinoid-infused beverages for the legalized medical and adult-use cannabis markets.

Management from both WeedMD and Phivida are collaborating on design and engineering strategies and site evaluations on a 610,000-square-foot, state-of-the art facility in Strathroy for the development of CanBev. As an emerging certified food grade production plant, the Strathroy facility is an ideal location and comes is equipped with extensive production infrastructure, including 50,000 sq. ft. of food production and packaging area, cold storage, loading docks, and adequate space to expand for future growth.

Strategic Agreements

Phivida Organics has also entered into an agreement to carry out a pharmacokinetic (PK) study on its hemp-derived, nanoencapsulated CBD with Artelo Biosciences Inc. at the University of Nottingham, School of Medicine at the Royal Derby Hospital, England. The study will test encapsulated-CBD on healthy volunteers and measure how fast and how much CBD enters the blood stream after oral consumption with each of the different formulations developed by Phivida Organics.

Phivida has also activated distribution agreements with Asayake Inc. to become one of the first federally approved CBD-infused food and supplement brands in Japan. With first mover status achieved, Phivida now markets to an underserved, yet highly informed population of 127 million patients and practitioners. The supplement market in Japan is estimated at US$10 billion with the overall functional foods market at US$21 billion. The Asia-Pacific region is the fastest growing market for natural plant-based supplements. Phivida now plans to prepare a formal application to Japan’s Consumer Affairs Agency to register the company’s CBD-infused functional food and beverage products for approval under the country’s Food with Functional Claims regime. The functional beverage market in Japan is estimated at US$10.35 billion with a CAGR of 2.5 percent (2015-2025).

Further Information
+1 (844) 744-6646 (ext. #2)

Phivida Holdings Inc. (PHVAF), closed the day's trading session at $0.404, off by 9.94%, on 28,946 volume with 23 trades. The average volume for the last 3 months is 76,700 and the stock's 52-week low/high is $0.05/$1.80.

Recent News


Sproutly Canada, Inc. (OTCQB: SRUTF) (CSE: SPR) (FRA: 38G)

The QualityStocks Daily Newsletter would like to spotlight Sproutly Canada, Inc. (SRUTF).

Sproutly Canada, Inc. (CSE: SPR) (OTCQB:SRUTF) (FRA: 38G) ("Sproutly" or the "Company") is pleased to announce that it has filed a final short form prospectus ("Prospectus") and obtained a receipt (the "Receipt") in each of the provinces of British Columbia, Alberta, Manitoba and Ontario to qualify the distribution of 15,400,000 equity units (the "Equity Units") issuable upon the deemed exercise of 15,400,000 equity special warrants (the "Equity Special Warrants") of the Company, and 10,750 convertible debenture units (the "CD Units") issuable upon the deemed exercise of 10,750 convertible debenture special warrants (the "CD Special Warrants" and, together with the Equity Special Warrants, the "Special Warrants") of the Company previously issued on October 24, 2018 on a private placement basis pursuant to prospectus exemptions under applicable securities legislation (the "Offering").

Sproutly Canada, Inc. (OTCQB: SRUTF) (TSX.V: SPR) (FRA: 38G) is developing and bringing to market cannabis consumer products with a focus on beverages. The company’s core mission is to become the leading supplier of water-soluble cannabis solutions and bio-natural oils for brands in the emerging cannabis beverage and edibles market.

To make this happen, Sproutly acquired Infusion Biosciences to bring to market a patent-pending Aqueous Phytorecovery Process (APP) technology, a fundamental paradigm shift within the cannabis industry. Replacing traditional water-compatible solutions with true natural water solubility improves the body’s ability to utilize cannabinoids, making the effect of the cannabis almost immediate.

This revolutionary process doesn’t alter the cannabis compounds and provides an onset time and offset time that mimics the same effects as inhaled marijuana. That means consumers may feel effects in five minutes or less and be free from the desired effect in approximately 90 minutes—a vastly different ingestion pattern than current methods. In addition, the water-based cannabinoids can be mixed with other liquids and stay dissolved in those liquids. The application of water-soluble cannabis infusions has potential to be widespread in both medicinal and recreational cannabis sectors, giving Sproutly a distinctive edge in a market with untapped potential.

Sproutly’s business model is focused on processing rather than cultivating, which means its success is not constrained to growing its own cannabis. The company does own a Toronto-based, ACMPR-licensed facility designed and built with a focus on cultivating pharmaceutical-grade cannabis to produce and formulate the first natural, truly water-soluble cannabis solution. Its water-soluble ingredients and bio-natural oils will deliver revolutionary brands to international markets that are searching for well-defined commercial products.

Sproutly’s entrance in the cannabis market is perfectly timed as cannabis is moving towards mainstream acceptance. Potential users are, however, interested in consuming cannabis products as drinks and using it as oils rather than smoking. The potential cannabis beverage market is staggering, and with Sproutly owning the exclusive rights to APP technology in Canada, Australia, Jamaica, Israel and the entire European Union, the company is looking at significant international expansion opportunities.

Sproutly plans to capitalize on these international opportunities by executing on partnerships with local and globally established consumer brands to leverage their existing customer bases, expand brand loyalty, and assist with marketing and support distribution networks to deliver scientific breakthroughs with speed and efficiency?worldwide.


Sproutly believes that talent drives growth. The company is committed to bringing together the best and brightest minds in the cannabis space to help with their mission to disrupt the global beverage and consumables market.

President, CEO and Director Keith Dolo recently served for more than 13 years with Robert Half, an S&P 500, NYSE-listed company. At Robert Half, Dolo held the position of vice president for more than eight years, as well as other senior roles in both operations and sales. He also sits on an advisory committee and a board position for two nonprofits in Vancouver, BC.

Chief Science Officer and Director Dr. Arup Sent has more than 35 years of experience in research and executive management at biotechnology and pharmaceutical companies. He was awarded a PhD in biochemistry from Princeton University and is a former faculty member at the National Cancer Institute and Scripps Research Institute. Sen is the inventor on five U.S. patents and numerous international patents and patent-pending applications.

Chief Financial Officer Craig Loverock is a chartered professional accountant with over 20 years of experience in accounting and finance roles in Canada, the United States and the United Kingdom. He has extensive expertise in public company reporting and transactional experience, having served as the senior financial advisor to the chairman at Magna International and acting as chief compliance officer and CFO for a private equity firm.

Head Grower Frank Han has over 12 years of experience in the horticulture industry. A previous master grower in a large commercial facility, Han has impressive expertise in all growing methods, techniques and procedures. He brings with him a wealth of knowledge in cloning, nutrient and overall plant management. Han will be in charge of the production team at Sproutly’s Toronto Herbal Remedies facility.

Sproutly Canada, Inc. (OTCQB: SRUTF), closed the day's trading session at $0.2601, off by 16.10%, on 217,966 volume with 121 trades. The average volume for the last 3 months is 207,096 and the stock's 52-week low/high is $0.189/$1.875.

Recent News


QMC Quantum Minerals Corp. (OTC: QMCQF) (TSX-V: QMC) (FSE: 3LQ)

The QualityStocks Daily Newsletter would like to spotlight QMC Quantum Minerals Corp. (QMCQF).

QMC Quantum Minerals (OTC: QMCQF) (TSX.V: QMC) (FSE: 3LQ) is currently wrapping up an action-packed year at its Irgon Lithium Mine Project and preparing to rapidly expand exploration in an effort to bring the project into production as soon as its qualified engineer has upgraded the historical resource estimate to be compliant with current NI 43-101 standards. To view the full article, visit:

QMC Quantum Minerals Corp. (OTC: QMCQF) (TSX-V: QMC) (FSE: 3LQ) is a British Columbia based company engaged in the business of acquisition, exploration and development of natural resource properties. QMC’s focus is on creating shareholder value through strategic acquisition and development of high quality lithium, silver, gold, nickel, copper and zinc prospects.

QMC’s current properties are in the Canadian province of Manitoba, one of Canada’s most productive, centrally located mining regions. These resources include the Irgon Lithium Mine project and two Volcanic Massive Sulphide (“VMS”) properties – the Rocky Lake and Rocky-Namew known collectively as the Namew Lake District Project – which contain base metal-rich mineral deposits. Excellent access and well-developed mining infrastructure to the company’s wholly-owned Irgon Lithium Mine Project offers significant value and ramps up the near-term production schedule, putting QMC in a position to take advantage of rising lithium prices.

The region’s historic resource estimate of lithium is well documented in a 1956 Assessment Report developed by a previous owner, Lithium Corporation of Canada Ltd. The project’s historical resource estimate of 1.2 million tons grading 1.51% lithium-oxide over a strike length of 365 meters and to a depth of 213 meters is being updated by QMC through a detailed channel sampling and subsequent drill program.

North Face Software Ltd. recently created an interactive 3-D model of the Irgon Dike utilizing all historical data derived from past drilling and underground work. The 3-D model clearly demonstrates that exploration and underground development has only taken place on the central portion of the dike, leaving significant potential to quickly increase tonnage.

The company’s latest assay results, obtained from 144 channel samples at QMC’s Irgon Lithium Mine Project, provided encouraging and positive results that compare favorably with the historic assays. QMC has received a drill permit from the Sustainable Development Office of the Manitoba government and is in the process of requesting and assessing bids from drilling contractors. The company plans to begin a 2,000-meter drill program to confirm the historic lithium oxide assay results documented in the historic 1953-54 drill program.

QMC’s experienced leadership team includes specialists in mineral exploration, geology, engineering, new business development, marketing and investor relations. The company’s team of qualified advisors includes consultant Bruce E. Goad, P.Geo., who has 40 years of experience in mineral exploration in Canada, Argentina, Asia and Africa. As a Qualified Person, Goad has worked on numerous deposit styles including rare element pegmatites, porphyry, banded iron formation (BIF) gold deposits, skarn, greisens,  and VMS. He has a wide and varied skill set which includes precious, base, industrial and rare metal projects with a sharp focus on gold exploration. Goad is the author of several scholarly publications on pegmatite granites of the southeastern Manitoba region.

The market for lithium has surged over the past three years with prices per metric ton tripling. The world’s rising demand for portable power can easily been seen in the electric vehicle and mobile device industries – both of which use lithium-based, renewable batteries as a power resource. QMC’s high potential prospects and experienced management team, both in geology and corporate finance, put QMC and its shareholders in an excellent position to take advantage of the lithium, precious and base metals markets.

QMC Quantum Minerals Corp. (QMCQF), closed the day's trading session at $0.1427, off by 14.04%, on 84,009 volume with 34 trades. The average volume for the last 3 months is 95,333 and the stock's 52-week low/high is $0.1427/$0.92.

Recent News


Global Payout, Inc. (GOHE)

The QualityStocks Daily Newsletter would like to spotlight Global Payout, Inc. (GOHE).

Global Payout, Inc. (GOHE) was featured today by CannabisNewsWire in a report on how the election of a new government in Mexico paved the way for quick steps to be made towards the legalization of recreational cannabis. Now the foreign minister of the country has told a Mexican Senate committee that lessons are going to be drawn from countries and jurisdictions where legalization has already occurred.

Global Payout, Inc. (GOHE) provides comprehensive payment solutions that can be fully customized for virtually any domestic and international organization distributing money worldwide. The company is committed to enabling global access to technology for optimizing financial transactions and delivering a global financial eco-system with top-tier banking institutions and the highest level financial technology partnerships.

Today, more than ever before, commercial enterprises and government institutions need powerful financial technology solutions that have the flexibility to deliver innovative customer centric services and drive operational efficiency gains throughout the organization. The Global Reserve Platform is Global Payout’s fully configurable “banking-in-a-box” web-based platform that can fulfill the front-to-back office processing requirements of domestic, foreign exchange and international payment service providers. This platform is designed to improve work flow, operational efficiencies, and global financial management for enterprises operating across the globe.

The Global Reserve Platform can manage practically any financial product, including core and traditional banking products, online banking, card management, mobile wallets, merchant payment processing, biometric payments and authentication management, bill payments and P2P payments, international remittances, government benefits management, loans management, FOREX, and SWIFT / ACH / SEPA payments. Powered by the Global Reserve Administrative module, the platform can be customized for enterprises across a multitude of business sectors.

Investment in financial technology (FINTECH) companies has grown dramatically in recent years with the role of today’s banks shrinking and demand for improved financial solutions continuing to rise. As the industry has continued to expand rapidly, Global Payout’s management team has directed its focus on identifying the most promising market sectors with FINTECH needs. The four core areas selected are logistics, small and medium enterprises (SME), banking and travel.

In 2015, Global Payout introduced MoneyTrac Technology Inc. as a majority owned subsidiary to more effectively focus on the development of financial technologies that specifically address many of the challenges that enterprises in a variety of alternative and “high-risk” market sectors are faced with in processing financial transactions. Powered by Virtu Network Solutions, the MoneyTrac Technology platform is one the most configurable and intuitive financial technology platforms available to alternative and “high-risk” enterprises and provides them with solutions that effectively manages everything from pin debit and virtual currency, to compliance and cash flow logistics.

With the global economy constantly becoming more diversified and connected, Global Payout is well positioned with the technology software solutions its team has developed to address many different needs worldwide. Management has committed itself to exploring and identifying every avenue possible for further establishing itself as a recognized leader in FINTECH solutions.

Global Payout, Inc. (GOHE), closed the day's trading session at $0.0053, off by 5.36%, on 8,770,608 volume with 124 trades. The average volume for the last 3 months is 7,901,765 and the stock's 52-week low/high is $0.005/$0.084.

Recent News


Medical Cannabis Payment Solutions (REFG)

The QualityStocks Daily Newsletter would like to spotlight Medical Cannabis Payment Solutions (REFG).

Companies working in the medical and recreational cannabis industry, like Medical Cannabis Payment Solutions (OTC: REFG), are celebrating a big win. A large farm bill, known as the Agriculture Improvement Act of 2018, was passed in the Senate, 20-1, and in the House of Representatives, 369-47 (

Medical Cannabis Payment Solutions (REFG), headquartered in Cheyenne, Wyoming, is a first-tier merchant processing cannabis industry pioneer, offering one of the first and only comprehensive card processing operations of its kind to serve the state-sanctioned medical marijuana industry. The company’s state of the art system, which also tracks sales and tax collection, and eliminates the need to deal in cash-only transactions.

Through its robust, closed-loop merchant processing system, the company’s unique “StateSourced” proprietary system enables authorized operation under FinCEN parameters and complies with all regulatory frameworks. StateSourced is tailored to deliver full-spectrum merchant processing services, providing the convenience of modern commercial card processing resources and making it the first operation of its kind geared to the legal cannabis industry.

StateSourced is not a prepaid or gift card, which is an important variable for merchants since standard banking institutions have not offered this form of payment processing to the legal cannabis industry. Federal law still considers marijuana illegal under the Controlled Substances Act, although 29 states and the District of Columbia have legalized the plant either for medicinal or recreational uses or both. This restriction has kept financial institutions at bay since most banks are federally insured and haven’t been inclined to venture into the nascent industry.

Medical Cannabis Payment Solutions is able to offer its StateSourced card on a state-by-state basis where the card can be used in purchasing product from a legal, authorized vendor, providing a much-needed option for consumers and businesses alike. In another first, the company is collaborating with First Bitcoin Capital Corporation to integrate First Bitcoin’s cryptocurrency ($Weed) with Medical Cannabis Payment Solutions’ StateSourced payment gateway. This collaboration will allow state-licensed marijuana establishments across the nation to accept both StateSourced debit cards and cryptocurrencies such as WeedCoin and Bitcoin.

Medical Cannabis Payment Solutions president and CEO Jeremy Roberts and his executive team are working with state lawmakers to introduce legislation in an effort to address the growing problems in banking for the medical cannabis industry. For companies in the emerging legal cannabis industry, where retail and non-retail transactions such as vendor payments and payroll are almost exclusively paid for with cash, the solutions offered by StateSourced can help businesses avoid the inherent risks associated with a cash-intensive sector. Medical Cannabis Payment Solutions has also signed its first StateSourced contract with a Las Vegas-based vertically integrated marijuana establishment.

“We’ve completed our transition from development stage to revenue stage,” says Roberts. “We have just started our business development efforts and the market is responding very well. We anticipate having many more, similar releases.”

Medical Cannabis Payment Solutions provides end-to-end management across multiple systems for medicinal marijuana operations. The company solves the fragmentation problem experienced by many of these rapidly growing companies by identifying tools that are important to dispensaries and customizing those tools to meet the specific needs of this unique industry.

Medical Cannabis Payment Solutions (REFG), closed the day's trading session at $0.0178, off by 17.21%, on 611,083 volume with 41 trades. The average volume for the last 3 months is 432,358 and the stock's 52-week low/high is $0.0127/$0.092.

Recent News


Zenergy Brands, Inc. (ZNGY)

The QualityStocks Daily Newsletter would like to spotlight Zenergy Brands, Inc. (ZNGY).

Zenergy Brands (OTC: ZNGY) is focused on the reduction of utility consumption for its commercial, industrial and municipal customers. To view the full article, visit:

Zenergy Brands, Inc. (ZNGY) is the nation’s leading next-generation energy and technology company operating in the emerging smart energy, conservation, and utility industries. Headquartered in Texas, Zenergy provides an entire suite of conservation-based products and services that enable clients to achieve sustainability goals, reduce carbon emissions and improve their bottom line. The company’s cutting-edge Zero Cost Program™ reduces utility expenses by 20 percent to 60 percent by offering energy conservation, smart controls, and efficiency-based products and services to residential, commercial, industrial and municipal end-use customers.

The Zero Cost Program™ is a financing mechanism that allows customers to reduce water, natural gas and electricity expenses by implementing proven conservation technologies at no out-of-pocket cost. The Zero Cost Program™ enriches businesses by immediately reducing energy consumption through the use of smart controls, building automation, LED lighting solutions, refrigeration optimization, efficient water systems, EC motor controls, demand-side management and load factor correction.

A unique Managed Energy Services Agreement (“MESA”) allows a portion of these utility savings to be retained by Zenergy’s partner financing the upgraded, retrofit equipment and installation costs until a specified repayment period ends. After that, clients reap all the financial rewards of the technologies implemented, which Zenergy estimates should range between 25 percent and 45 percent of total utility costs.

Residential customers seeking cost-effective energy savings can also choose from a suite of “Smart Home” products including home automation, security monitoring, and energy conservation services that can be controlled 24/7 from the comfort and convenience of their smartphones or internet-connected smart devices. Zenergy’s residential program offers partnership opportunities for homebuilders and residential, multi-family real estate developers to provide smart home technologies to high-end customers.

Zenergy Brands’ acquisition of Enertrade Electric LLC, a fully operating, licensed Texas-based Retail Electric Provider (REP), further increases the company’s value proposition. Zenergy CEO Alex Rodriguez said this new subsidiary adds an essential complementary service to the company’s suite of smart energy products and services.

“Since our founding, our vision has been to converge smart controls (home and building automation) with energy conservation and retail energy to deliver the comprehensive smart energy service to customers,” Rodriguez said.

On a global scale, residential and commercial buildings account for nearly 45 percent of the world’s total energy consumption. Improving the energy efficiency of these homes and buildings is often a more affordable way to reduce harmful gas emissions while minimizing the need for new energy production. According to Navigant Research, global revenue for energy-efficient commercial building retrofits alone is expected to grow from $71.4 billion in 2016 to $100.8 billion in 2025. At the same time, the energy-efficient devices market is expected to reach a market size of $908 billion by 2022. Increasing demands for reduction in energy consumption and greenhouse gas emissions along with concerns over climate change are contributing factors driving the market’s overall growth.

Zenergy Brands, Inc. (ZNGY), closed the day's trading session at $0.0001, up 900.00%, on 36,766,356 volume with 13 trades. The average volume for the last 3 months is 48,514,731 and the stock's 52-week low/high is $0.000009/$0.013.

Recent News


The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal

The QualityStocks Sponsored News

The QualityStocks DailyNetwork Sponsors

ActionStockPicksAgressive StocksBetting On Wall StreetCannabisNewsWireGot Stocks?Got Stock Tips?Green Car StocksGreen Energy StocksGreen On The StreetHomeRunStocksMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireQualityStocks MediaQStocksQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsStock BeatsStocks To Buy NowTerrificStocksTiny GemsTip.usTouchdownStocksDaily ToutTraderPower

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.